PHD inhibition may not have attenuated malignant hypertension, because renovascular hypertension already resulted in a strong HIF-2α accumulation in glomerular (presumably endothelial) cells, which could not be further increased by the PHD inhibitor. Here, EPAS1 is linked to renovascular hypertension.